Figure 3.
Polygenic risk score-stratified analysis for Mendelian randomization study of FGF23 and heart failure. Figure: An eGFR polygenic risk score was developed using summary statistics from the Chronic Kidney Disease Genetics Consortium (CKDGen) genome-wide association study of eGFR in >1 million individuals and stratified MR analyses of FGF23 and heart failure were performed across eGFR polygenic risk score strata.